Abstract
Background
To investigate the long-term effect of hypertensive phase (HP) on the clinical outcomes of Ahmed glaucoma valve (AGV) implantation.
Method
The records of patients with different etiologies of glaucoma who underwent AGV implantation with at least 3 years of follow-up were retrospectively reviewed. HP was defined as the IOP > 21 mm Hg during the first three months after surgery. The main outcome measure was cumulative success defined as 5 < IOP ≤ 21 mmHg and 20% reduction from the baseline with or without IOP lowering medications. Results that do not achieve cumulative success or undergo glaucoma reoperation during the follow-up period are considered failures. The secondary outcome measures were intraocular pressure (IOP) and the number of glaucoma medications.
Results
A total of 120 patients (28 patients of HP, 92 patients without HP) with an average age (± SD) of 48.9 ± 19.6 years and a mean follow-up of 4.5 ± 1.4 years were enrolled. The mean duration of survival was 5.3 ± 0.5 years in HP which was significantly shorter than 6.4 ± 0.2 years in non-HP (log rank = 4.2, P = 0.04). Mean IOP and number of IOP lowering agents were higher in postoperative visits at 1,2, 3, and 4 years in HP patients compared with non-HP (all Ps < 0.01). Higher baseline IOP was significantly associated with higher rates of surgical failure.
Conclusion
In the long-term follow-up, the duration of survival was significantly longer in the non-HP group. In the non-HP group, the failure rate was significantly lower than the HP group.
Similar content being viewed by others
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Wilson MR, Mendis U, Paliwal A, Haynatzka V (2003) Long-term follow-up of primary glaucoma surgery with Ahmed glaucoma valve implant versus trabeculectomy. Am J Ophthalmol 136(3):464–470
Gedde SJ, Schiffman JC, Feuer WJ, Herndon LW, Brandt JD, Budenz DL, Tube versus Trabeculectomy Study Group (2012) Treatment outcomes in the tube versus trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol 153(5):789–803
Fargione RA, Tansuebchueasai N, Lee R, Tai TYT (2019) Etiology and management of the hypertensive phase in glaucoma drainage-device surgery. Surv Ophthalmol 64(2):217–224
Ayyala RS, Duarte JL, Sahiner N (2006) Glaucoma drainage devices: state of the art. Expert Rev Med Devices 3(4):509–521
Ayyala RS, Zurakowski D, Smith JA, Monshizadeh R, Netland PA, Richards DW, Layden WE (1998) A clinical study of the Ahmed glaucoma valve implant in advanced glaucoma. Ophthalmology 105(10):1968–1976
Pitukcheewanont O, Tantisevi V, Chansangpetch S, Rojanapongpun P (2018) Factors related to hypertensive phase after glaucoma drainage device implantation. Clin Ophthalmol (Auckland, NZ) 12:1479
Won HJ, Sung KR (2016) Hypertensive phase following silicone plate Ahmed glaucoma valve implantation. J Glaucoma 25(4):e313–e317
Cheng J, Beltran-Agullo L, Buys YM, Moss EB, Gonzalez J, Trope GE (2016) Flow test to predict early hypotony and hypertensive phase after Ahmed Glaucoma Valve (AGV) surgical implantation. J Glaucoma 25(6):493–496
Jung KI, Park CK (2016) Risk factors for the hypertensive phase after implantation of a glaucoma drainage device. Acta Ophthalmol 94(5):e260–e267
Tsai JC, Johnson CC, Kammer JA, Dietrich MS (2006) The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma II: longer-term outcomes from a single surgeon. Ophthalmology 113(6):913–917
Christakis PG, Kalenak JW, Tsai JC, Zurakowski D, Kammer JA, Harasymowycz PJ, Ahmed II (2016) The Ahmed versus Baerveldt study: five-year treatment outcomes. Ophthalmology 123(10):2093–2102
Budenz DL, Feuer WJ, Barton K, Schiffman J, Costa VP, Godfrey DG, Silva Y (2016) Postoperative complications in the Ahmed Baerveldt comparison study during five years of follow-up. Am J Ophthalmol 163:75–82
Ayyala RS, Zurakowski D, Monshizadeh R, Hong CH, Richards D, Layden WE, Bellows AR (2002) Comparison of double-plate Molteno and Ahmed glaucoma valve in patients with advanced uncontrolled glaucoma. Ophthalmic Surg Lasers Imaging Retina 33(2):94–99
Nouri-Mahdavi K, Caprioli J (2003) Evaluation of the hypertensive phase after insertion of the Ahmed Glaucoma Valve. Am J Ophthalmol 136(6):1001–1008
Jeong HJ, Park HYL, Park CK (2018) Effects of early postoperative intraocular pressure after Ahmed glaucoma valve implantation on long-term surgical outcomes. Korean J Ophthalmol 32(5):391–399
Molteno AC, Fucik M, Dempster AG, Bevin TH (2003) Otago glaucoma surgery outcome study: factors controlling capsule fibrosis around Molteno implants with histopathological correlation. Ophthalmology 110(11):2198–2206
Lee J, Park CK, Jung KI (2020) Initial glaucoma medication in the hypertensive phase following ahmed valve implantation: a comparison of results achieved using aqueous suppressants and prostaglandin analogs. J Clin Med 9(2):416
Jung KI, Park H, Jung Y, Park CK (2015) Serial changes in the bleb wall after glaucoma drainage implant surgery: characteristics during the hypertensive phase. Acta Ophthalmol 93(4):e248–e253
Yuen D, Buys Y, Jin YP, Alasbali T, Smith M, Trope GE (2011) Corticosteroids versus NSAIDs on intraocular pressure and the hypertensive phase after Ahmed glaucoma valve surgery. J Glaucoma 20(7):439–444
Freedman J, Iserovich P (2013) Pro-inflammatory cytokines in glaucomatous aqueous and encysted Molteno implant blebs and their relationship to pressure. Invest Ophthalmol Vis Sci 54(7):4851–4855
Budenz DL, Barton K, Gedde SJ, Feuer WJ, Schiffman J, Costa VP, Ahmed Baerveldt Comparison Study Group (2015) Five-year treatment outcomes in the Ahmed Baerveldt comparison study. Ophthalmology 122(2):308–316
Yazdani S, Doozandeh A, Pakravan M, Ownagh V, Yaseri M (2017) Adjunctive triamcinolone acetonide for Ahmed glaucoma valve implantation: a randomized clinical trial. Eur J Ophthalmol 27(4):411–416
Foo VHX, Htoon HM, Welsbie DS, Perera SA (2019) Aqueous shunts with mitomycin C versus aqueous shunts alone for glaucoma. Cochrane Database of Systematic Reviews, (4)
Pakravan M, Rad SS, Yazdani S, Ghahari E, Yaseri M (2014) Effect of early treatment with aqueous suppressants on Ahmed glaucoma valve implantation outcomes. Ophthalmology 121(9):1693–1698
Funding
No funding was received.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Ethical approval
All procedures in this study were approved by the Ethics Committee of the Eye Research Center, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
Consent to participate
Written informed consent was obtained from each participant.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Nilforushan, N., Hassanpour, K., Vafaei, F. et al. The effect of the hypertensive phase on the long-term outcomes of Ahmed glaucoma valve (AGV) implantation. Int Ophthalmol 42, 3739–3747 (2022). https://doi.org/10.1007/s10792-022-02371-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-022-02371-w